nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances and prospects in glucose assay technology
|
Gough, D. A. |
|
1997 |
40 |
supplement-2 |
p. S102-S107 |
artikel |
2 |
Alteration in brain glucose metabolism induced by hypoglycaemia in man
|
Boyle, P. J. |
|
1997 |
40 |
supplement-2 |
p. S69-S74 |
artikel |
3 |
Alternative insulin delivery systems: how demanding should the patient be?
|
Polonsky, K. S. |
|
1997 |
40 |
supplement-2 |
p. S97-S101 |
artikel |
4 |
Antihypertensive treatment and mortality in diabetic patientsWhat is the evidence?
|
Sawicki, P. T. |
|
1997 |
40 |
supplement-2 |
p. S134-S137 |
artikel |
5 |
Are presently available insulin analogues clinically beneficial?
|
Berger, M. |
|
1997 |
40 |
supplement-2 |
p. S91-S96 |
artikel |
6 |
Cardiovascular effects of sulphonylurea derivatives
|
Smits, P. |
|
1997 |
40 |
supplement-2 |
p. S160-S161 |
artikel |
7 |
Control of PHAS-I phosphorylation in 3T3-L1 adipocytes: effects of inhibiting protein phosphatases and the p70S6K signalling pathway
|
Lin, T.-A. |
|
1997 |
40 |
supplement-2 |
p. S18-S24 |
artikel |
8 |
Coronary heart disease and risk factors in NIDDM – experience from the United Kingdom Prospective Diabetes Study
|
Turner, R. C. |
|
1997 |
40 |
supplement-2 |
p. S121-S122 |
artikel |
9 |
Cytosolic NADH/NAD+ , free radicals, and vascular dysfunction in early diabetes mellitus
|
Ido, Y. |
|
1997 |
40 |
supplement-2 |
p. S115-S117 |
artikel |
10 |
Diabetes mellitus, dyslipoproteinaemias and atherosclerosis
|
Steiner, G. |
|
1997 |
40 |
supplement-2 |
p. S147-S148 |
artikel |
11 |
Endothelial control of vascular tone in diabetes mellitus
|
Poston, L. |
|
1997 |
40 |
supplement-2 |
p. S113-S114 |
artikel |
12 |
Engineered cell lines for insulin replacement in diabetes: current status and future prospects
|
Newgard, C. B. |
|
1997 |
40 |
supplement-2 |
p. S42-S47 |
artikel |
13 |
Factors regulating the expression of vascular permeability/vascular endothelial growth factor by human vascular tissues
|
Williams, B. |
|
1997 |
40 |
supplement-2 |
p. S118-S120 |
artikel |
14 |
Heart abnormalities in IDDM
|
Fisher, B. M. |
|
1997 |
40 |
supplement-2 |
p. S127-S129 |
artikel |
15 |
Hypoglycaemia in diabetes mellitus – protecting the brain
|
Amiel, S. A. |
|
1997 |
40 |
supplement-2 |
p. S62-S68 |
artikel |
16 |
Impaired glucose tolerance – is it relevant for cardiovascular disease?
|
Haffner, S. M. |
|
1997 |
40 |
supplement-2 |
p. S138-S140 |
artikel |
17 |
Inflammation in the vascular wall as an early event in atherosclerosis
|
Prescott, S. M. |
|
1997 |
40 |
supplement-2 |
p. S111-S112 |
artikel |
18 |
Influence of diabetes mellitus on the heart and macrovascular mortality
|
Standl, E. |
|
1997 |
40 |
supplement-2 |
p. S125-S126 |
artikel |
19 |
Insulin resistance due to hyperglycaemia: an adaptation protecting insulin-sensitive tissues
|
Yki-Järvinen, H. |
|
1997 |
40 |
supplement-2 |
p. S141-S144 |
artikel |
20 |
Intensive insulin therapy in clinical practice
|
Home, P. D. |
|
1997 |
40 |
supplement-2 |
p. S83-S87 |
artikel |
21 |
Is insulin vasculotoxic?
|
Yudkin, J. S. |
|
1997 |
40 |
supplement-2 |
p. S145-S146 |
artikel |
22 |
LDL heterogeneity: implications for atherogenicity in insulin resistance and NIDDM
|
Betteridge, D. J. |
|
1997 |
40 |
supplement-2 |
p. S149-S151 |
artikel |
23 |
Microdialysis techniques in the study of brain and skeletal muscle
|
Maggs, D. G. |
|
1997 |
40 |
supplement-2 |
p. S75-S82 |
artikel |
24 |
Microvascular heart disease in diabetes mellitus
|
Goodfellow, J. |
|
1997 |
40 |
supplement-2 |
p. S130-S133 |
artikel |
25 |
Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor
|
Ish-Shalom, D. |
|
1997 |
40 |
supplement-2 |
p. S25-S31 |
artikel |
26 |
Modifications in the B10 and B26–30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor
|
Slieker, L. J. |
|
1997 |
40 |
supplement-2 |
p. S54-S61 |
artikel |
27 |
Molecular basis and promise of genetic therapy for diabetic dyslipidaemia: studies in an animal model of diabetes
|
Chan, L. |
|
1997 |
40 |
supplement-2 |
p. S155-S156 |
artikel |
28 |
Pharmacological reversal of advanced glycation end-product-mediated protein crosslinking
|
Ulrich, P. |
|
1997 |
40 |
supplement-2 |
p. S157-S159 |
artikel |
29 |
Predictors of coronary heart disease and death in NIDDM: The Diabetes Intervention Study experience
|
Hanefeld, M. |
|
1997 |
40 |
supplement-2 |
p. S123-S124 |
artikel |
30 |
Signal transduction mechanisms in nutrient-induced insulin secretion
|
Prentki, M. |
|
1997 |
40 |
supplement-2 |
p. S32-S41 |
artikel |
31 |
The insulin signalling system and the IRS proteins
|
White, M. F. |
|
1997 |
40 |
supplement-2 |
p. S2-S17 |
artikel |
32 |
The new era of biotech insulin analogues
|
Brange, J. |
|
1997 |
40 |
supplement-2 |
p. S48-S53 |
artikel |
33 |
The pathogenesis of atherosclerosis
|
Gerrity, R. G. |
|
1997 |
40 |
supplement-2 |
p. S108-S110 |
artikel |
34 |
The pathogenetic role of impaired fatty acid trapping by adipocytes in generating the pleiotropic features of hyperapoB
|
Sniderman, A. D. |
|
1997 |
40 |
supplement-2 |
p. S152-S154 |
artikel |
35 |
Translating the Diabetes Control and Complications Trial (DCCT) into clinical practice: overcoming the barriers
|
Zinman, B. |
|
1997 |
40 |
supplement-2 |
p. S88-S90 |
artikel |